Lisa Suennen is a co-founder and Managing Member of Psilos Group, a healthcare-focused venture capital firm with approximately $600 million under management. Ms Suennen has headed Psilos' West Coast office since the firm's founding in 1998 and focuses on the healthcare information technology, healthcare services and medical technology sectors. She currently serves as a Director on the Board of several Psilos portfolio companies, including AngioScore, PatientSafe Solutions, OmniGuide, and VeraLight. She is also a board member of Miraculins (TSX-V:MOM).
Prior to Psilos, Ms. Suennen was at Merit Behavioral Care (formerly American Biodyne, Inc), where she held various senior executive roles including Senior Vice President of Sales and Marketing, Senior Vice President/General Manager of the Public Sector Division (a $300 million business unit) and Senior Vice President of Pacific Region Operations. Lisa joined Merit in 1988 while still in its early start-up period and, during her nine-year tenure, played a key role in its growth to an $800 million/year company. While at Merit, she also participated in the acquisition and integration of regional managed care companies, the company's IPO in 1991, and the company's sale to Magellan Health for $800 million in 1998.
Previously, Lisa served as Worldwide Product Manager for INGRES/Relational Technology, Inc., a relational database company, where she had responsibility for development, marketing and distribution of the company's UNIX PC software product. Prior to INGRES, Lisa served as Director of U.S. Market Development and as Manager, U.S. Government and Industry Relations for X/Open, an international computer industry standards setting and lobbying consortium. Earlier, Lisa spent several years at Regis McKenna, Inc., an international high technology marketing and public relations firm, responsible for government relations and public relations strategy for client companies in the software and healthcare areas.
Lisa holds an M.A. in political science, a B.A. in political science and a B.A. in mass communications, all from the University of California, Berkeley. Lisa has returned to UC Berkeley as Vice Chair of the National Advisory Council of the Institute of Governmental Studies at the University and as visiting lecturer at the U.C. Berkeley Haas School of Business where, together with Dr. Jeff Rideout, she teaches the annual course on healthcare venture capital.
Lisa has served as a member of the Advisory Board of the U.S. Health and Human Services Office of the National Coordinator Investing in Innovations program. She is currently a member of the Qualcomm Life Advisory Board, a member of the Dignity Health Foundation Board and a member of the Board of health IT company Beyond Lucid Technologies.
In 2013 Lisa was named to the Healthcare IT News HIT Top 100 List. In 2011 Lisa was the recipient of the Director of the Year Award (Companies in Transition) from the Corporate Director's Forum. In 2011 she was also was awarded the U.C. Berkeley Institute for Governmental Studies Outstanding Alumni Award.
Lisa writes a widely read blog on healthcare and healthcare investing found at www.venturevalkyrie.com. Lisa is proud to note that this blog has been highlighted on the Forbes/Women 2.0 VC Women Who Blog List, on MedCity News' list of 12 powerful female voices in healthcare innovation and social media, and on Health IT News' list of the Top 10 bloggers to follow on Twitter.
Click here for Printer-friendly Bio (pdf)
If you do not already have Adobe Acrobat Reader, click here to download.
Lisa Suennen explains how Psilos' strategic investment philosophy provides strong relationships and results with their portfolio companies.